These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33207023)

  • 21. Markers of bone metabolism in children with nephrotic syndrome treated with corticosteroids.
    Pańczyk-Tomaszewska M; Adamczuk D; Kisiel A; Skrzypczyk P; Przedlacki J; Górska E; Stelmaszczyk-Emmel A; Demkow U; Roszkowska-Blaim M
    Adv Exp Med Biol; 2015; 840():21-8. PubMed ID: 25310960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of bone turnover status on the efficacy and safety of denosumab among haemodialysis patients.
    Hori M; Yasuda K; Takahashi H; Kondo C; Shirasawa Y; Ishimaru Y; Sekiya Y; Morozumi K; Maruyama S
    Sci Rep; 2022 May; 12(1):7781. PubMed ID: 35546172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
    Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ
    Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Bone Turnover Biomarkers in Lead-Battery Workers with Long-Term Exposure to Lead.
    Kalahasthi R; Barman T; Bagepally BS
    Int J Occup Environ Med; 2020 Jul; 11(3):140-147. PubMed ID: 32683426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered levels of BMD, PRL, BAP and TRACP-5b in male chronic patients with schizophrenia.
    Du X; Ye F; Li J; Zhao Y; Xiao W; Tang X; Zhang X
    Sci Rep; 2020 Aug; 10(1):13598. PubMed ID: 32788631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG).
    Sasaki N; Kusano E; Takahashi H; Ando Y; Yano K; Tsuda E; Asano Y
    J Bone Miner Metab; 2005; 23(1):41-7. PubMed ID: 15616893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cross-sectional study exploring useful indicators for low bone mineral density in male alcoholic patients.
    Horai T; Hishimoto A; Otsuka I; So T; Mouri K; Shimmyo N; Boku S; Okishio N; Sora I
    Neuropsychiatr Dis Treat; 2018; 14():663-669. PubMed ID: 29535522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
    Terpos E; de la Fuente J; Szydlo R; Hatjiharissi E; Viniou N; Meletis J; Yataganas X; Goldman JM; Rahemtulla A
    Int J Cancer; 2003 Sep; 106(3):455-7. PubMed ID: 12845688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density.
    Halleen JM; Ylipahkala H; Alatalo SL; Janckila AJ; Heikkinen JE; Suominen H; Cheng S; Väänänen HK
    Calcif Tissue Int; 2002 Jul; 71(1):20-5. PubMed ID: 12073156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between biochemical markers and radial cortical bone changes in hemodialysis patients.
    Fujimori A; Okada S; Sakai M; Tome K; Fukagawa M
    Nephron Clin Pract; 2011; 118(4):c375-9. PubMed ID: 21325869
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone mineral density and vitamin D status in children with remission phase of steroid-sensitive nephrotic syndrome.
    Cetin N; Gencler A; Sivrikoz IA
    Saudi J Kidney Dis Transpl; 2019; 30(4):853-862. PubMed ID: 31464242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Equol and Resveratrol Improve Bone Turnover Biomarkers in Postmenopausal Women: A Clinical Trial.
    Corbi G; Nobile V; Conti V; Cannavo A; Sorrenti V; Medoro A; Scapagnini G; Davinelli S
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of serum tartrate-resistant acid phosphatase isoform 5b, bone alkaline phosphatase and osteocalcin in osteoporotic fractures in Chinese patients.
    Cao Y; Liu X; Xu H
    Clin Lab; 2012; 58(7-8):845-50. PubMed ID: 22997989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of osteoporosis medication on changes in bone mineral density and bone turnover markers after 24-month administration of daily teriparatide: comparison among minodronate, raloxifene, and eldecalcitol.
    Nakatoh S
    J Bone Miner Metab; 2018 Mar; 36(2):221-228. PubMed ID: 28293779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of calcitriol in treating glucocorticoidinduced osteoporosis in patients with nephrotic syndrome: an open-label, randomized controlled study.
    Chen Y; Wan JX; Jiang DW; Fu BB; Cui J; Li GF; Chen CM
    Clin Nephrol; 2015 Nov; 84(5):262-9. PubMed ID: 26396095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between bone turnover markers and the heel stiffness index measured by quantitative ultrasound in post-menopausal Japanese women.
    Nishimura T; Arima K; Abe Y; Kanagae M; Mizukami S; Okabe T; Tomita Y; Goto H; Hasegawa M; Sou Y; Horiguchi I; Aoyagi K
    Ann Hum Biol; 2019 Jun; 46(4):330-334. PubMed ID: 30995879
    [No Abstract]   [Full Text] [Related]  

  • 37. Zoledronic acid sequential therapy could avoid disadvantages due to the discontinuation of less than 3-year denosumab treatment.
    Kondo H; Okimoto N; Yoshioka T; Akahoshi S; Fuse Y; Ogawa T; Okazaki Y; Katae Y; Tsukamoto M; Yamanaka Y; Kawasaki M; Sakai A
    J Bone Miner Metab; 2020 Nov; 38(6):894-902. PubMed ID: 32656645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab.
    Miyazawa Y; Sekine Y; Syuto T; Nomura M; Koike H; Matsui H; Shibata Y; Ito K; Suzuki K
    Anticancer Res; 2017 Jul; 37(7):3667-3671. PubMed ID: 28668858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone impairment caused by AlCl
    Yang X; Yu K; Wang H; Zhang H; Bai C; Song M; Han Y; Shao B; Li Y; Li X
    Food Chem Toxicol; 2018 Jun; 116(Pt B):307-314. PubMed ID: 29704576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Affect of Lifestyle on Bone Mineral Density and Bone Turnover in Young Women.
    Motooka N; Matsuo H
    Kobe J Med Sci; 2020 Feb; 65(4):E124-E131. PubMed ID: 32201427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.